Intravenous Administration: General Characteristics and Risks
Intravenous administration (Injectio intravenosa) is a critical parenteral route in which a drug is delivered directly into the systemic circulation. A key feature of this method is the virtually complete absence of a latent period. The pharmacological effect occurs instantly, which in clinical practice is described as a "needle-action" effect.
Due to its speed, the intravenous route is a primary tool in emergency medical care. In addition, it is widely used for scheduled course treatments in both inpatient and outpatient settings.
However, the direct entry of a drug into the systemic circulation carries specific risks and disadvantages:
- Inability to rapidly reverse the effect: This is the primary disadvantage of the method. Once a drug is administered, its action cannot be promptly stopped, which is critically dangerous in the event of an accidental overdose or anaphylaxis.
- Risk of infection: Aseptic technique failure can lead to tissue infection.
- Venous thrombosis: Local thrombosis may develop at the injection site due to the irritating effect of the drug or mechanical vessel damage.
- Painfulness: Injections can cause patient discomfort.
- Organizational complexity: The procedure requires absolute sterility and can only be performed by qualified medical personnel.
Requirements for Dosage Forms
Far from all dosage forms are suitable for intravenous administration. A core pharmacological rule establishes that primarily aqueous solutions (solutiones aquosae) are injected into veins. Hypertonic solutions are also clinically acceptable. The only exception where lipid media are permitted is factory-produced specialized lipid nano/microemulsions.
It is strictly prohibited to inject into the vascular bed:
- Oil solutions (solutiones oleosae).
- Any suspensions (particle dispersions).
- Solutions containing visible gas bubbles.
The reason for this strict prohibition lies in the extremely high risk of embolism—the occlusion of blood vessels by insoluble oil droplets, solid particles, or air bubbles, which can lead to fatal consequences.
Technique and Administration Regimens
Depending on treatment goals and drug characteristics, intravenous administration is carried out in two main regimens:
1. Bolus (Slow Push) Administration Performed using a syringe, with the drug administered gradually over approximately one minute. In most cases, preliminary dilution of the drug substance is required (e.g., in isotonic 0.9% sodium chloride solution). The main goal of slow bolus administration is to avoid creating a dangerous peak concentration of the active substance in vital organs such as the heart, lungs, and major arteries.
2. Infusion (Drip) Administration This regimen is used to administer large fluid volumes. It requires specialized infusion sets that allow precise regulation of the solution delivery rate. The rate is typically set within 20–60 drops per minute, equivalent to 1–3 milliliters per minute. Infusion is indicated, in particular, for drugs with a short half-life (e.g., lidocaine) when it is necessary to maintain a stable blood concentration over an extended period.
Intra-arterial and Intrasternal Administration
In addition to the venous bed, other specific routes are used in medical practice.
Intra-arterial Administration (Injectio intraarterialis) The rationale behind this method is injecting the drug directly into the artery supplying a specific organ. The pharmacokinetic goal is to achieve the highest possible local concentration of the drug in the target organ tissues while minimizing systemic effects. Strictly designated groups of drugs are administered intra-arterially:
- Antineoplastic agents (cytostatics) for localized tumor impact.
- Radiocontrast agents for diagnostic angiography.
- In selected complex cases, antibiotics.
Intrasternal Administration (Injectio intrasternalis) With this access, the drug is injected directly into the spongy bone of the sternum. The main indication for an intrasternal injection is the acute impossibility of establishing standard venous access. Most frequently, this backup method is used in specific target groups: children and elderly patients in whom catheterization of peripheral or central veins may be difficult.